Molecular and Clinical Heterogeneity in Hungarian Patients with Treacher Collins Syndrome—Identification of Two Novel Mutations by Next-Generation Sequencing
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252111400 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Gréta Antal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry, Oral and Maxillofacial Surgery, Clinical Center, Medical School, University of Pécs, 7623 Pécs, Hungary. Hauptthemen laut MEDLINE: Mandibulofacial Dysostosis, High-Throughput Nucleotide Sequencing, Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Pécs, Medical School, Research Fund, University of Pécs Medical School Research Fund.
Abstract (Originalsprache)
Treacher Collins syndrome (TCS) is a rare congenital craniofacial disorder with variable penetrance and high genetic and phenotypic heterogeneity. It is caused by pathogenic variants in the TCOF1, POLR1D, POLR1C, and POLR1B genes, and its major characteristic features are malar and mandibular hypoplasia, downward slanting of the palpebral fissures, and conductive hearing loss. In this study, five patients (two males and three females, age range from 2 to 29 years) with TCS were tested by Next-Generation Sequencing (NGS)-based sequencing and clinically characterized. Genetic analyses detected two deletions and one insertion in the TCOF1 gene and one missense variant in the POLR1D gene. Two novel mutations, c.1371_1372insT (p.Lys458*) in the TCOF1 gene and c.295 G>C (p.Gly99Arg) in the POLR1D gene, were identified. Moreover, two already known mutations, c.4369_4373del (p.Lys1457Glufs*12) and c.2103_2106del (p.Ser701Argfs*9) in the TCOF1 gene, were detected. The novel TCOF1 c.1371_1372insT mutation was associated with mild craniofacial manifestations and very rare symptoms of TCS, i.e., developmental delay and moderate intellectual disability. Although incomplete penetrance is a known phenomenon in TCS, surprisingly, the majority of our patients inherited the disease-causing variants from an asymptomatic mother. The unique feature of our study is the observation of causative mutation transmission between asymptomatic family members. Our results expanded the clinical and mutational spectrum of TCS and further confirmed the inter- and intra-familial variability of this disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dentistry, Oral and Maxillofacial Surgery, Clinical Center, Medical School, University of Pécs, 7623 Pécs, Hungary.
- Department of Medical Genetics, Clinical Center, Medical School, University of Pécs, 7624 Pécs, Hungary.
ORCID-Profile: András Szabó, Anita Maász, Judit Bene, Kinga Hadzsiev
Förderung
- University of Pécs, Medical School, Research Fund
- University of Pécs Medical School Research Fund
Zitieren
APA
Antal, G., Zsigmond, A., Till, Á., Szabó, A., Maász, A., Bene, J., & Hadzsiev, K. (2024). Molecular and Clinical Heterogeneity in Hungarian Patients with Treacher Collins Syndrome—Identification of Two Novel Mutations by Next-Generation Sequencing. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111400
Vancouver
Antal G, Zsigmond A, Till Á, Szabó A, Maász A, Bene J, et al. Molecular and Clinical Heterogeneity in Hungarian Patients with Treacher Collins Syndrome—Identification of Two Novel Mutations by Next-Generation Sequencing. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111400
BibTeX
@article{Antal2024,
author = {Antal, Gréta and Zsigmond, Anna and Till, Ágnes and Szabó, András and Maász, Anita and Bene, Judit and Hadzsiev, Kinga},
title = {Molecular and Clinical Heterogeneity in Hungarian Patients with Treacher Collins Syndrome—Identification of Two Novel Mutations by Next-Generation Sequencing},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252111400}
}
EUVIMED